BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11717158)

  • 1. Cardiac-specific external paths for lidocaine, defined by isoform-specific residues, accelerate recovery from use-dependent block.
    Lee PJ; Sunami A; Fozzard HA
    Circ Res; 2001 Nov; 89(11):1014-21. PubMed ID: 11717158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
    Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel.
    Sunami A; Glaaser IW; Fozzard HA
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2326-31. PubMed ID: 10681444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues.
    Liu H; Atkins J; Kass RS
    J Gen Physiol; 2003 Mar; 121(3):199-214. PubMed ID: 12601084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The voltage dependence of recovery from use-dependent block by QX-222 separates mechanisms for drug egress in the cardiac sodium channel.
    Lardin HA; Lee PJ
    Biochem Pharmacol; 2006 Apr; 71(9):1299-1307. PubMed ID: 16637111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and gating changes of the sodium channel induced by mutation of a residue in the upper third of IVS6, creating an external access path for local anesthetics.
    Sunami A; Glaaser IW; Fozzard HA
    Mol Pharmacol; 2001 Apr; 59(4):684-91. PubMed ID: 11259611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels.
    Sheets MF; Hanck DA
    J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium channel selectivity filter regulates antiarrhythmic drug binding.
    Sunami A; Dudley SC; Fozzard HA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14126-31. PubMed ID: 9391164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific lidocaine block of sodium channels explained by differences in gating.
    Nuss HB; Kambouris NG; Marbán E; Tomaselli GF; Balser JR
    Biophys J; 2000 Jan; 78(1):200-10. PubMed ID: 10620286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
    McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
    J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
    Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
    Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium channel molecular conformations and antiarrhythmic drug affinity.
    Sheets MF; Fozzard HA; Lipkind GM; Hanck DA
    Trends Cardiovasc Med; 2010 Jan; 20(1):16-21. PubMed ID: 20685573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quaternary ammonium block of mutant Na+ channels lacking inactivation: features of a transition-intermediate mechanism.
    Kimbrough JT; Gingrich KJ
    J Physiol; 2000 Nov; 529 Pt 1(Pt 1):93-106. PubMed ID: 11080254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels.
    Li RA; Ennis IL; Tomaselli GF; Marbán E
    Mol Pharmacol; 2002 Jan; 61(1):136-41. PubMed ID: 11752214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
    Pugsley MK; Goldin AL
    Eur J Pharmacol; 1998 Jan; 342(1):93-104. PubMed ID: 9544797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine alters activation gating of cardiac Na channels.
    Hanck DA; Makielski JC; Sheets MF
    Pflugers Arch; 2000 Apr; 439(6):814-21. PubMed ID: 10784357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.
    Zamponi GW; French RJ
    Biophys J; 1993 Dec; 65(6):2335-47. PubMed ID: 8312473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the action of lidocaine on insect sodium channels.
    Song W; Silver KS; Du Y; Liu Z; Dong K
    Insect Biochem Mol Biol; 2011 Jan; 41(1):36-41. PubMed ID: 20888415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium increases potency of lidocaine-induced block of voltage-gated Na+ currents in rat sensory neurons in vitro.
    Gold MS; Thut PD
    J Pharmacol Exp Ther; 2001 Nov; 299(2):705-11. PubMed ID: 11602684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using lidocaine and benzocaine to link sodium channel molecular conformations to state-dependent antiarrhythmic drug affinity.
    Hanck DA; Nikitina E; McNulty MM; Fozzard HA; Lipkind GM; Sheets MF
    Circ Res; 2009 Aug; 105(5):492-9. PubMed ID: 19661462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.